Novo Nordisk's pricing strategies from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, mentioning the stark distinction amongst U.S. costs and those in Europe and copyright.Understanding the output prices is important for anyone seeking to navigate the complexities of prescripti